The second program of AAFP’s Annual Clinical Focus 2005 Genomics went live March 7, offering FPs and other clinicians targeted information on the genetics of breast cancer.
To access this ACF offering, go here and click on “Breast Cancer Program.” From that page, you can link to an online video CME program, Web tour of resources, post-test and evaluation form, and related materials.
Check Out ACF 2005 Genomics Program on Breast Cancer
By News Staff
This story first appeared in the March 18, 2005, AAFP Direct.
Included in the Web tour are links to a downloadable genogram template clinicians can use to record patients’ family histories and to other family history and screening tools. Other links guide program participants to the Web sites of various national organizations and governmental agencies that provide information about genetic testing to detect hereditary susceptibility for breast and ovarian cancers. There’s even a link to an index of genetic counselors by geographic region and area of specialization.
According to family physician Nancy Stevens, M.D., medical director for the 2005 ACF, it’s not surprising that the outpouring of media coverage about the so-called breast cancer genes BRCA1 and BRCA2 has prompted a surge of requests for genetic testing to detect those anomalies.
“What isn’t as clear -- and what this program will emphasize -- is where tests for these uncommon mutations fit in our management of breast cancer risk, screening procedures and other treatments,” Stevens says in the video.
The video program highlights the importance of assessing patients’ multiple risks for breast cancer, including family history, and discussing recommended screening strategies with them. The program also focuses on recognizing individuals whose presentation or history would suggest an increased risk for one of the BRCA mutations.
“Managing the risk of breast cancer in these patients is an example of our essential role in helping patients sort through the complexity of options in the context of their own lives,” says Stevens.
Earn up to one free CME credit for completing the program’s post-test. And don’t forget the 20 CME credits you can earn by participating in a practice-based quality improvement project on collecting and recording patients’ family histories. The project, offered as part of this year’s ACF, has a link on the Web site noted above.
According to family physician Nancy Stevens, M.D., medical director for the 2005 ACF, it’s not surprising that the outpouring of media coverage about the so-called breast cancer genes BRCA1 and BRCA2 has prompted a surge of requests for genetic testing to detect those anomalies.
“What isn’t as clear -- and what this program will emphasize -- is where tests for these uncommon mutations fit in our management of breast cancer risk, screening procedures and other treatments,” Stevens says in the video.
The video program highlights the importance of assessing patients’ multiple risks for breast cancer, including family history, and discussing recommended screening strategies with them. The program also focuses on recognizing individuals whose presentation or history would suggest an increased risk for one of the BRCA mutations.
“Managing the risk of breast cancer in these patients is an example of our essential role in helping patients sort through the complexity of options in the context of their own lives,” says Stevens.
Earn up to one free CME credit for completing the program’s post-test. And don’t forget the 20 CME credits you can earn by participating in a practice-based quality improvement project on collecting and recording patients’ family histories. The project, offered as part of this year’s ACF, has a link on the Web site noted above.
